chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt. states that after the 1st dose of High-Dose Influenza 09/28/2021, started experiencing symptoms 09/29/2021 of dry coughing, joint pain, and fatigue. Primary Follow-Up 10/12/2021 no recommendations. Symptoms have subsided.
Caller states she had fluid behind her ears and the doctor said it was probably from the typical sinus infection she gets from allergies.; Caller states she had fluid behind her ears and the doctor said it was probably from the typical sinus infection she gets from allergies.; Tested positive for Covid 19, after receiving both doses of the Covid vaccine.; Tested positive for Covid 19, after receiving both doses of the Covid vaccine.; This is a spontaneous report from a contactable consumer (patient). A 68-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection), dose 2 via an unspecified route of administration on 13Feb2021 (Batch/Lot Number: EN6201) as DOSE 2, SINGLE, dose 1 via an unspecified route of administration on 21Jan2021 (at the age of 68-years-old) (Batch/Lot Number: EL3247) as DOSE 1, SINGLE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient reports her and her male friend were vaccinated in Jan2021 and Feb2021 and her friend was recently diagnosed with Covid and she said this makes her nervous. The patient states actually, yesterday she was diagnosed with Covid as well (medically significant) on 04Aug2021 17:30, and it freaked her out. She states she wears a mask and she got the shots at , and just to find out had she has Covid, she couldn't believe it. She states she hope y'all give us a booster soon. she started with a little cough on Saturday on 31Jul2021 and she went to the doctor on Monday. She states she had fluid behind her ears and the doctor said it was probably from the typical sinus infection she gets from allergies. Patient states the antibiotic he prescribed she was allergic to, so she didn't take it. She states while she was waiting from them to change it, in the meantime, she went to take her friend to get tested and she was tested as well. She states he had bad chills, and all this stuff. She states all she had was a bad cough. Bad headache on 04Aug2021. She did let everyone know that she had been around that she got Covid. She states she was freaking out and she wears masks. She states this makes her think the Delta variant was dangerous. She states now she had a bad headache, she had intermittent spurts of the cough and headache. She states she will have her friend call and report for himself. She states he got a lot sicker than she did. She asks, does call handler think they are going to get a booster for us. She was going to go take some Advil because she has a bad headache. Headache and cough was not recovered. The patient underwent lab test and procedure included Covid-19 test with positive result on 04Aug2021 17:30. The outcome of all events outcome was unknown.
A physician reported that a 19 month old child received an injection of Prevnar and a few days later, developed a "cloudy right cornea". The child was seen by the physician and dx'd with keratitis. A culture was positive for Streptococcus viridans which the reporter believed was a "skin contaminant". The pt is being treated with an unspecified topical antibiotic".
Swelling and redness left elbow to shoulder; Seen in ER with diagnosis of cellulitis; Treatment: Prednisone, regimen of Keflex 250 mg 1 po q 6 hrs x 10 days and Tylenol #3 PRN.
Initial report was received on 11 October 2011 from a health care professional, which involved a cluster of three female patients who experienced adverse events after receiving FLUZONE INTRADERMAL (lot number not reported). This case captures one of the female patients. The other two patients have been captured in case number 2011-09897 and 2011-09898. A female patient (date of birth not reported) had received on 27 September 2011 a left deltoid injection of FLUZONE INTRADERMAL (lot number not reported) and had an immediate localized reaction of swelling, redness, warmth and a lump. The patient then developed an itchy rash on her right knee with warmth, swelling and redness (onset not reported) that persisted for five to six days. On 30 September 2011, the patient developed a lump on her lower left forearm with warmth and swelling that was still present. According to the reporter, the injection site continued to have the lump and was itchy. No further information was available at the time of the report. Outcome was not recovered. Documents held by sender: none.
Fever; Chills; This is a spontaneous report received from contactable reporter(s) (Pharmacist) from a sales representative.  A male patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), as dose number unknown, single (Batch/Lot number: unknown) for immunisation; for immunisation; influenza vaccine (INFLUENZA VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "recovered", described as "Fever"; CHILLS (non-serious), outcome "recovered".  The information on the batch/lot number for rsv vaccine prot.subunit pref 2v, rsv vaccine prot.subunit pref 2v  has been requested and will be submitted if and when received.
scarring on the right hand; Open sores/there are no more open sores on the hand./legs are still covered with what looks like small ulcers; Blister starts; Infection/infection comes back again if they are open and has scabs over it; This spontaneous case was reported by a consumer and describes the occurrence of SCAR (scarring on the right hand), SKIN ULCER (Open sores/there are no more open sores on the hand./legs are still covered with what looks like small ulcers), BLISTER (Blister starts) and INFECTION (Infection/infection comes back again if they are open and has scabs over it) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and METOPROLOL for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SCAR (scarring on the right hand), SKIN ULCER (Open sores/there are no more open sores on the hand./legs are still covered with what looks like small ulcers), BLISTER (Blister starts) and INFECTION (Infection/infection comes back again if they are open and has scabs over it). The patient was treated with CEFTRIAXONE (CEFTIN [CEFTRIAXONE]) at an unspecified dose and frequency and SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) at an unspecified dose and frequency. At the time of the report, SCAR (scarring on the right hand), SKIN ULCER (Open sores/there are no more open sores on the hand./legs are still covered with what looks like small ulcers), BLISTER (Blister starts) and INFECTION (Infection/infection comes back again if they are open and has scabs over it) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications include Adderall and metoprolol(Toprol)
Yellow fever vaccine administered 6/7/10. On 6/18/10, pt experienced headache, muscle weakness, tachycardia and anxiety. Seen by PMD who examined and did (unknown) blood work. On inquiry, pt failed to reveal hx of malaria, "tick fever", and removal/dissection of benign liver tumor in 9/07. F/u on 6/25/10 sx had abated except residual, mild fatigue.
On 8/28/12 FLUMIST was sprayed into right eye, when child suddenly moved. 1/2 of full dose was sprayed into eye. Eye was wiped with tissue. No adverse effects after 10 minutes. Call to mother 48 hours later indicated no eye or other health problems. Child was not revaccinated against flu,
more and more palpitations; Fluctuating heart rate; heart issues (PVCs and pots disease); heart issues (PVCs and pots disease); My blood pressure is all over the place; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "heart issue" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PALPITATIONS (non-serious), outcome "unknown", described as "more and more palpitations"; HEART RATE IRREGULAR (non-serious), outcome "unknown", described as "Fluctuating heart rate"; VENTRICULAR EXTRASYSTOLES (non-serious), POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (non-serious), outcome "unknown" and all described as "heart issues (PVCs and pots disease)"; BLOOD PRESSURE ABNORMAL (non-serious), outcome "unknown", described as "My blood pressure is all over the place".  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300185235 same patient, same vaccine, similar events, different dose (4th);
ADMITTED TO HOSPITAL AFTER PRESUMED FALL, FOUND TO BE POSITIVE FOR COVID-19 ON ADMISSION.  NOTED TO BE ASYMPTOMATIC CURRENTLY.
he had a hive that was probably 3 inch x 2 inch on his arm that did not get the injection; A few hours later he started itching his right arm; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRURITUS (A few hours later he started itching his right arm) and URTICARIA (he had a hive that was probably 3 inch x 2 inch on his arm that did not get the injection) in a 2-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1412B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jul-2022, the patient experienced PRURITUS (A few hours later he started itching his right arm). On 22-Jul-2022 at 5:30 PM, the patient experienced URTICARIA (he had a hive that was probably 3 inch x 2 inch on his arm that did not get the injection). The patient was treated with CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) in July 2022 for Itchy upper limbs and Hives, at an unspecified dose and frequency. In July 2022, PRURITUS (A few hours later he started itching his right arm) and URTICARIA (he had a hive that was probably 3 inch x 2 inch on his arm that did not get the injection) had resolved.            Concomitant medication of the patient was not reported.   The patient received the injection around 12 pm.  The reporter also called the primary care provider of the patient to inform about the reaction. After giving Claritin, the itching stopped and hives disappeared. The patient had no additional issues after Claritin was given.
left side headache, left eye pain, severe vomiting, full body pain, neck pain, chills as of Sunday some had subsided but not all.  tylenol of no use!
This medically confirmed spontaneous report (initial receipt 28-OCT-2014) concerns a 56 year old male patient. On 26-OCT-2014, AFLURIA underwent temperature excursion at 50 degree Fahrenheit. On 27-OCT-2014, AFLURIA again had temperature excursion at 50 degree Fahrenheit for undetermined amount of time. On 27-OCT-2014, the patient received temperature excursion AFLURIA (batch number: T50507) via intramuscular route at 0.5 ml. Outcome was reported as unknown. Reporter's comments: The reporter assessed the event as non-serious.
Information has been received from a county health professional concerning a 10 year old male who on 06-FEB-1998 was vaccinated with varicella virus vaccine live (Oka/Merck). On 22-FEB-2007, the patient developed varicella, < 50 lesions. The nurse reported that an outbreak of varicella had taken place in the local school district in April 2007, and this student was identified during the county health investigation. An immunization clinic was conducted in the school where students received a second dose of varicella virus vaccine live (Oka/Merck). This is one of 28 reports received from the same source. No further information is available.
Started having fever and then started swelling at the injection site. Then got RSV (respiratory infection).
Muscle pain, stiffness in deltoid of left arm that became progressively worse throughout the night.  Difficulty moving, rotating, lifting left arm.  Could not lie on arm in bed.  Muscle did not feel hot; nor was there fever.  Stiffness, soreness persists into next day.
Fatigue, muscle aches, chills, apparent fever (did not take temperature). Symptoms started about 6 hours post injection, persisted throughout the night and are currently present (24 hours post injection).  Some pain at injection site but not more than any other injection.  Ibuprofen (200mg every 4 - 6 hours) reduces severity of symptoms somewhat.
pt recvd vax & 24hrs later exp upper arm swelling & pain inj site;sx still persist
Patient was admitted to the hospital for acute appendicitis on 3/29. She subsequently required respiratory support with high flow nasal cannula and remains admitted currently (4/6/21)
period delayed for 4 days; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION DELAYED (period delayed for 4 days) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to Sulfa).    On 10-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Sep-2021, the patient experienced MENSTRUATION DELAYED (period delayed for 4 days). At the time of the report, MENSTRUATION DELAYED (period delayed for 4 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants medication were provided.  No treatment medication were provided.  Second dose is scheduled on 8-Oct-2021.
Information has been received from a health professional concerning a 22 month old female with no medical history and no known drug allergies, who on 08/10/2000 was vaccinated with the first dose of varicella vaccine in the left thigh. Concomitant therapy, that same day included the fourth dose of Act-Hib in the right thigh and the third dose of IPOL in the right thigh. There was no illness at the time of vaccination. On 6/19/2001, the pt was seen in the physician's office and diagnosed with chicken pox. The rash was first noticed two to three days prior, on approximately 06/16/2001. At the time of the office visit, the rash was described as extensive, appearing especially in the diaper area, but all over as well. The rash was itchy, but the pt was afebrile. Follow-up info from a health professional notd that the pt presented at the physician's office on 06/18/2001 with pox like rash that started on that same day. The pt had greater than 100 pox on groin area, upper leg, abdomen, torso, chest, arms and around face. The diagnosis was varicella. The pt was afebrile and the lungs were clear. The pt recovered without complication. No further info is expected.
Headache, NauseaVomiting, Arm soreness at injection site, neck tightness Narrative:
Vaccine was given to patient on Left Thigh. Vaccine had expired on 10/04/2020. Informed Provider of incident and informed patient guardian of incident and patient stayed for 20 minutes to make sure no side affects were notices. Patient did not show any symptoms while waiting in clinic so they left.
extreme weakness/from her brainstem down through her back was really weak; When got the vaccine on Sunday it was administered very slowly, about 15 seconds; This is a spontaneous report from a contactable consumer (patient). A 74-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EN6198), via an unspecified route of administration, administered in arm right on 07Mar2021 (at the age of 74-years-old) as dose 1, single for COVID-19 immunisation. Medical history included high blood pressure, thyroid and lost a lot of weight prior to vaccine. Concomitant medications included lisinopril 50mg taking for years; aspirin [acetylsalicylic acid] 81mg less than 2 months; carvedilol 12.5mg taking for years, all 3 taken for high blood pressure and levothyroxine 25mg less than 2 months taken for thyroid. On 07Mar2021, the patient experienced . The patient reported that she received the Pfizer vaccine on 07Mar2021 (Sunday) and had some extreme weakness. When the patient got the vaccine on Sunday, it was administered very slowly, about 15 seconds. It seemed like it was hard to go in. She further reported that she could not seemed okay but was kind of weak, when she got home the next day on 08Mar2021, had extreme weakness, could hardly life up her head, from her brainstem down through her back was really weak. She could get up have breakfast and then at 12 she had to lay back down. She felt a tad bit better on 09Mar2021. She asked was it an aqueous solution or oily solution and how long did the vaccine take to administer, because the person on site, stated the vaccine went in very slowly, like an oily substance. The outcome of the event weakness was not resolved.  No follow-up attempts are possible. No further information is expected.
Pt presented with round sores on forehead and side of face. Pt complained also of headaches claims shot gave him shingles.
1 week after shots, fever for four days, clear nasal and throat phlegm. Taken to ER and was given medications to dry up secretions. Mom reports she was told he had a viral infection. He was well after 5 days.
Redness, swelling, heat at the site of injection that was not alcohol prepped prior to injection.
passed out; Severe allergy(hives all over my body even between my fingers); had a headaches for hours and hours; broke my leg; Severe allergy(hives all over my body even between my fingers); Pfizer Biontech 3rd Booster; Pfizer Biontech 3rd Booster; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 57-years old, via an unspecified route of administration, administered in Arm Left on 10Sep2021 13:00 (Batch/Lot number was not reported) as dose 3, single for COVID-19 immunization. Medical history included asthma. The patient had no known allergies. There were no concomitant medications. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. The patient experienced severe allergy (hives all over her body even between her fingers). She was still in recuperating; she also had a headaches for hours and hours and then she was taking a shower and passed out and broke her leg multiples places. The events occurred on 11Sep2021 03:00 which resulted to healthcare professional office/clinic visit and emergency room/department or urgent care. The patient received Prednisone 60mg 3 Times a day as treatment. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab test and procedures which included nasal swab: negative on 28Dec2020. The outcome of the events was not recovered.   Information on the lot/batch number has been requested.
Tongue became very painful, with what appear to be painful raised taste buds toward the back of the tongue. The side of my tongue also still seems to be infected with sometimes painful sores.
My dad got a flu; Initial information regarding an unsolicited valid non-serious case received from social media on 15-Nov-2020 from a consumer (patient's son/daughter).  This case involved a male patient of unknown age who got a flu (Influenza), while received vaccine INFLUENZA VACCINE.  the patient's medical history, medical treatment, vaccination details, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for Prophylactic vaccination.  Ona n unknown date, the patient got a flu (influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.  It was also reported that shot spent next week with extremely bad flu. All of the symptoms almost died.  No laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the reported event.  There will be no information available on batch number for this case.
A 65 year old female received ADACEL (lot number unknown) intramuscularly in the left deltoid and PNEUMOVAX (manufacturer Merck, lot number unknown) on 28 July 2009. On 29 July 2009 the patient developed an 18 cm diameter area of erythema, fever of 101, and pain at the site. The patient did not develop lymphadenopathy. The patient was seen in the emergency room and was started on KEFLEX. The next day the patient was seen in the doctor's office with no improvement and was started on clindamycin. A of 01 August 2009 the patient was 33-50% improved. WBC was 12 and seg 83%. No further information was provided. List of Documents held by Sender: none.
Pt was riding home in their car. Had arms crossed over chest, making strange noise, eyes rolled back, body jerking. Mother thinks seizure lasted 30 seconds.
red rough rash, itchy onset 01/06/21 seen PCP treated with Kenalog injection and  MEDROL DOSE PACK 6 DAY
Information has been received from a nurse concerning a 24 year old female who on 18-SEP-2007 was vaccinated intramuscularly (site not reported) with the 1st 0.5ml dose of Gardasil vaccine (lot# not reported). On approximately 20-NOV-2007, the patient was vaccinated intramuscularly (site not reported) with the 2nd 0.5mL dose of Gardasil vaccine (lot# 657617/0384U). The nurse reported that after the patient received the 2nd dose she developed soreness a the the injection site. The area was hot to the touch, warm, red and twice the size of her regular arm. It was not reported if the patient sought medical attention. At the time of this report the patient was recovering. Additional information has been requested. This is in follow-up to report (s) previously submitted on 12/14/2007. Initial and follow up information has been received from a registered nurse (RN) concerning a 24 year old female with no known drug allergies, who on 18-SEP-2007 was vaccinated IM (site not reported) with the first dose 0.5ml. of GARDASIL vaccine (lot # not reported), and on 20-NOV-2007 vaccinated IM in the left deltoid with the second dose 0.5ml. of GARDASIL vaccine (lot# 657617/0384U). There was no illness at the time of vaccination. On 29-NOV-2007, the RN reported that the patient called the office to report that on 20-NOV-2007, after she received the second dose, she developed a "severe local reaction," described as soreness at the injection site, with the area feeling hot to touch, red, and swollen to twice the size of her regular arm. The patient did not required a visit to the physician's office. At the time of this report the patient had recovered (duration and date not provided), though she was considering not completing the vaccination series. Additional information is not expected.
fever to 103 in 12hr;morbilliform rash @ 48hr;swollen red inj site @ 12hr;